Most of us don't realize how much better our skin, hair, and nails could look
Immunovant's IMVT1402: A potential first-in-class therapy for 6 diseases We would like to share a very interesting IgG-lowering therapeutics from Immunovants latest update, which highlights a strategic pivot toward the clinical advancement of its lead #FcRn inhibitor, #IMVT1402, positioning it as a potential first- and best-in-class therapy across 6 autoantibody-driven diseases
A comparative review of escitalopram, paroxetine, and sertraline: are they all alike
In an interview with Next Steps in Derm, author Christopher Bunick, MD, PhD, shares the panels evidencebased process, graded recommendations, and practical implications for clinic
Mechanisms of GHK-Cu Peptide Copper is both indispensable and possibly hazardous: it is crucial for enzymatic and redox activities, yet excessive amounts can lead to oxidative damage
Is Holt Medical Practice providing this service
